General Information of the Compound
| Compound ID |
CP0170877
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-(4-bromophenyl)-2-pyrrolidin-1-yl-pentan-1-one
Show/Hide
|
||||||||||||||||||
| Synonyms |
1-(4-bromophenyl)-2-(pyrrolidin-1-yl)pentan-1-one
1-(4-bromophenyl)-2-pyrrolidin-1-yl-pentan-1-one
1-Pentanone, 1-(4-bromophenyl)-2-(1-pyrrolidinyl)-
2-(Pyrrolidin-1-yl)-1-(4-bromophenyl)pentan-1-one
4'-Bromo-alpha-pyrrolidinopentiophenone
4-Bromo-alpha-pvp
BDBM50182578
CHEMBL202420
SCHEMBL4937387
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C15H20BrNO
|
||||||||||||||||||
| Molecular Weight |
310.235
|
||||||||||||||||||
| Canonical SMILES |
CCCC(N1CCCC1)C(=O)c1ccc(Br)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C15H20BrNO/c1-2-5-14(17-10-3-4-11-17)15(18)12-6-8-13(16)9-7-12/h6-9,14H,2-5,10-11H2,1H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
RAHKQMUBMIJUFG-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00884, Sodium-dependent dopamine transporter
Protein ID: PT01026, Sodium-dependent noradrenaline transporter
Protein ID: PT00871, Sodium-dependent serotonin transporter
Clinical Information about the Compound